CC BY-NC-ND 4.0 · Revista Argentina de Radiología / Argentinian Journal of Radiology 2020; 84(01): 017-029
DOI: 10.1055/s-0040-1702993
Revisión de tema
Sociedad Argentina de Radiología. Publicado por Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Neuroblastoma olfatorio. Todo lo que el radiólogo debe saber

Olfactory Neuroblastoma. Everything the Radiologist Should Know
Raquel Navas-Campo
1   Hospital Clínico Universitario Lozano Blesa, Zaragoza, España
,
Leticia Moreno Caballero
1   Hospital Clínico Universitario Lozano Blesa, Zaragoza, España
,
Ana Gasos Lafuente
1   Hospital Clínico Universitario Lozano Blesa, Zaragoza, España
,
Pilar Tobajas Morlana
1   Hospital Clínico Universitario Lozano Blesa, Zaragoza, España
,
Eduardo Séez Valero
1   Hospital Clínico Universitario Lozano Blesa, Zaragoza, España
,
María José Gimeno Peribáñez
1   Hospital Clínico Universitario Lozano Blesa, Zaragoza, España
› Author Affiliations
Fuentes de financiación No han existido fuentes de financiación para la realización de este trabajo.
Further Information

Publication History

02 September 2019

22 January 2020

Publication Date:
31 March 2020 (online)

Resumen

El neuroblastoma olfatorio (NBO) es un tumor maligno poco frecuente que se origina de las células neuroepiteliales olfativas. Su diagnóstico precoz es difícil debido a la poca especificidad de los síntomas que presentan los pacientes. Las pruebas de imagen juegan un papel importante en su diagnóstico y en la planificación quirúrgica, por lo que es importante que los radiólogos conozcan sus hallazgos y las diferentes clasificaciones que ayudarán a elegir el tratamiento más adecuado para cada tumor.

Abstract

Olfactory neuroblastoma (ONB) is a rare malignant tumor that originates from olfactory neuroepithelial cells. Its early diagnosis is difficult due to the low specificity of the symptoms. Imaging tests play an important role in its diagnosis and surgical planning so it is important that radiologists know their findings and the different classifications that will help to choose the most appropriate treatment for each tumor.

Responsabilidades Éticas

Protección de personas y animales. Los autores declaran que para esta investigación no se han realizado experimentos en seres humanos ni en animales.


Confidencialidad de los datos. Los autores declaran que han seguido los protocolos de su centro de trabajo sobre la publicación de datos de pacientes.


Derecho a la privacidad y consentimiento informado. Los autores declaran que en este artículo no aparecen datos de pacientes.


 
  • Bibliografía

  • 1 Bell D, Franchi A, Gillison M, Thompson LDR, Wenig BM. Olfactory neuroblastoma. En: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. , eds. WHO classification of head and neck tumors. 4th ed. Lyon: IAC Press; 2017: 57-59
  • 2 Berger L, Luc R, Richard D. L'esthesioneuroepitheliome Olfactif. Bull Assoc Fr Etud Cancer. 1924; 13: 410-421
  • 3 Su SY, Bell D, Hanna EY. Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment. Int Arch Otorhinolaryngol. 2014; 18 (02) (Suppl. 02) S149-S156
  • 4 Bell D, Saade R, Roberts D, Ow TJ, Kupferman M, DeMonte F. , et al. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015; 9 (01) 51-59
  • 5 Ow TJ, Bell D, Kupferman ME, Demonte F, Hanna EY. Esthesioneuroblastoma. Neurosurg Clin N Am. 2013; 24 (01) 51-65
  • 6 Faragalla H, Weinreb I. Olfactory neuroblastoma: a review and update. Adv Anat Pathol. 2009; 16 (05) 322-331
  • 7 Holbrook EH, Wu E, Curry WT, Lin DT, Schwob JE. Immunohistochemical characterization of human olfactory tissue. Laryngoscope. 2011; 121 (08) 1687-1701
  • 8 Trojanowski JQ, Lee V, Pillsbury N, Lee S. Neuronal origin of human esthesioneuroblastoma demonstrated with anti-neurofilament monoclonal antibodies. N Engl J Med. 1982; 307 (03) 159-161
  • 9 Carney ME, O'Reilly RC, Sholevar B, Buiakova OI, Lowry LD, Keane WM. , et al. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma). Neurooncol. 1995; 26 (01) 35-43
  • 10 Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol. 2002; 15 (03) 264-278
  • 11 Barnes L, Eveson JW, Reichart P, Sidransky D. Pathology and genetics of head and neck tumours. World Health Organization (WHO) Classification of Tumours. Lyon: IARC Press; 2005: 168-175
  • 12 Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg. 2007; 133 (03) 276-280
  • 13 Platek ME, Merzianu M, Mashtare TL, Popat SR, Rigual NR, Warren GW. , et al. Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol. 2011; 6: 41
  • 14 Chao KS, Kaplan C, Simpson JR, Haughey B, Spector GJ, Sessions DG. , et al. Esthesioneuroblastoma: the impact of treatment modality. Head Neck. 2001; 23 (09) 749-757
  • 15 Spaulding CA, Kranyak MS, Constable WC, Stewart FM. Esthesioneuroblastoma: a comparison of two treatment eras. Int J Radiat Oncol Biol Phys. 1988; 15 (03) 581-590
  • 16 Dias FL, Sa GM, Lima RA, Kligerman J, Leoncio MP, Freitas EQ. , et al. Patterns of failure and outcome in esthesioneuroblastoma. Arch Otolaryngol Head Neck Surg. 2003; 129 (11) 1186-1192
  • 17 Levine PA, McLean WC, Cantrell RW. Esthesioneuroblastoma: the University of Virginia experience 1960-1985. Laryngoscope. 1986; 96 (07) 742-746
  • 18 Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer. 1976; 37 (03) 1571-1576
  • 19 Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope. 1992; 102 (08) 843-849
  • 20 Rinaldo A, Ferlito A, Shaha AR, Wei WI, Lund VJ. Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications. Acta Otolaryngol. 2002; 122 (02) 215-221
  • 21 Monroe AT, Hinerman RW, Amdur RJ, Morris CG, Mendenhall WM. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head Neck. 2003; 25 (07) 529-534
  • 22 Davis RE, Weissler MC. Esthesioneuroblastoma and neck metastasis. Head Neck. 1992; 14 (06) 477-482
  • 23 Winn HR. Youmans neurological surgery: brain, spine, and peripheral nerve trauma in adults and children. Elsevier Health Sciences; 2014
  • 24 Larbcharoensub N, Kanoksil W, Cheewaruangroj W, Wiratkapun C, Sitathanee C, Sirachainan E. Esthesioneuroblastoma metastasis to the breast: A case report and review of the literature. Oncol Lett. 2014; 8 (04) 1505-1508
  • 25 Schuster JJ, Phillips CD, Levine PA. MR of esthesioneuroblastoma (olfactory neuroblastoma) and appearance after craniofacial resection. AJNR Am J Neuroradiol. 1994; 15 (06) 1169-1177
  • 26 Shah K, Perez-Ordóñez B. Neuroendocrine neoplasms of the sinonasal tract: neuroendocrine carcinomas and olfactory neuroblastoma. Head Neck Pathol. 2016; 10 (01) 85-94
  • 27 Bell D, Hanna E, Weber R, DeMonte F, Triantafyllou A, Lewis Jr. , et al. Neuroendocrine neoplasms of the sinonasal region. Head Neck. 2016; 38 (Suppl. 01) E2259-E2266
  • 28 Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF, Bullock MJ. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract. Am J Surg Pathol. 2011; 35 (12) 1786-1793
  • 29 Argani P, Perez-Ordoñez B, Xiao H, Caruana SM, Huvos AG, Ladanyi M. Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression. Am J Surg Pathol. 1998; 22 (04) 391-398
  • 30 Hyams V, Batsakis J, Michaels L. Tumors of the upper respiratory tract and ear. Armed forces institute of pathology fascicles, 2nd series. Washington: American Registry of Pathology Press; 1988
  • 31 Wenig BM. Undifferentiated malignant neoplasms of the sinonasal tract. Arch Pathol Lab Med. 2009; 133 (05) 699-712
  • 32 Purdy Stout A, Lattes R. Atlas of tumor pathology. Washington: Armed Forced Institute of Pathology; 1967
  • 33 Bradley PJ, Jones NS, Robertson I. Diagnosis and management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surg. 2003; 11 (02) 112-118
  • 34 Kaur G, Kane AJ, Sughrue ME, Madden M, Oh MC, Sun MZ. , et al. The prognostic implications of Hyam's subtype for patients with Kadish stage C esthesioneuroblastoma. J Clin Neurosci. 2013; 20 (02) 281-286
  • 35 Dublin AB. Imaging characteristics of olfactory neuroblastoma. J Neurol Surg B Skull Base. 2007; 17 (S1): A091
  • 36 Lund VJ, Milroy C. Olfactory neuroblastoma: clinical and pathological aspects. Rhinology. 1993; 31 (01) 1-6
  • 37 Bailey BJ, Barton S. Olfactory neuroblastoma. Management and prognosis. Arch Otolaryngol. 1975; 101 (01) 1-5
  • 38 Bak M, Wein RO. Esthesioneuroblastoma: a contemporary review of diagnosis and management. Hematol Oncol Clin North Am. 2012; 26 (06) 1185-1207
  • 39 Ow TJ, Hanna EY, Roberts DB. , et al. Optimization of long-term outcomes for patients with esthesioneuroblastoma. Head Neck. 2014; 36 (04) 524-530
  • 40 Holland H, Koschny R, Krupp W. , et al. Comprehensive cytogenetic characterization of an esthesioneuroblastoma. Cancer Genet Cytogenet. 2007; 173 (02) 89-96
  • 41 Bockmühl U, You X, Pacyna-Gengelbach M, Arps H, Draf W, Petersen I. CGH pattern of esthesioneuroblastoma and their metastases. Brain Pathol. 2004; 14 (02) 158-163
  • 42 Guled M, Myllykangas S, Frierson Jr HF, Mills SE, Knuutila S, Stelow EB. Array comparative genomic hybridization analysis of olfactory neuroblastoma. Mod Pathol. 2008; 21 (06) 770-778
  • 43 Modesto A, Blanchard P, Tao YG, Rives M, Janot F, Serrano E. , et al. Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma. Oral Oncol. 2013; 49 (08) 830-834
  • 44 Suriano M, De Vincentiis M, Colli A, Benfari G, Mascelli A, Gallo A. Endoscopic treatment of esthesioneuroblastoma: a minimally invasive approach combined with radiation therapy. Otolaryngol Head Neck Surg. 2007; 136 (01) 104-107
  • 45 Ward PD, Heth JA, Thompson BG, Marentette LJ. Esthesioneuroblastoma: results and outcomes of a single institution's experience. Skull Base. 2009; 19 (02) 133-140
  • 46 Josephs L, Jones L, Marenette L, McKeever P. Cushing's syndrome: an unusual presentation of olfactory neuroblastoma. Skull Base. 2008; 18 (01) 73-76
  • 47 Koo BK, An JH, Jeon KH, Choi SH, Cho YM, Jang HC. , et al. Two cases of ectopic adrenocorticotropic hormone syndrome with olfactory neuroblastoma and literature review. Endocr J. 2008; 55 (03) 469-475
  • 48 Plasencia YL, Cortés MB, Arencibia DM, Dámaso TM, Contreras IL, Pino AO. , et al. Esthesioneuroblastoma recurrence presenting as a syndrome of inappropriate antidiuretic hormone secretion. Head Neck. 2006; 28 (12) 1142-1146
  • 49 Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001; 2 (11) 683-690
  • 50 Manelfe C, Bonafé A, Fabre P, Pessey JJ. Computed tomography in olfactory neuroblastoma: one case of esthesioneuroepithelioma and four cases of esthesioneuroblastoma. J Comput Assist Tomogr. 1978; 2 (04) 412-420
  • 51 Ahmed M, Knott PD. Hyperostotic esthesioneuroblastoma: rare variant and fibrous dysplasia mimicker. Korean J Radiol. 2014; 15 (01) 156-160
  • 52 Howell MC, Branstetter IV BF, Snyderman CH. Patterns of regional spread for esthesioneuroblastoma. AJNR Am J Neuroradiol. 2011; 32 (05) 929-933
  • 53 Ahmad A, Branstetter IV BF. CT versus MR: still a tough decision. Otolaryngol Clin North Am. 2008; 41 (01) 1-22 , v
  • 54 Ling FTK, Kountakis SE. Advances in imaging of the paranasal sinuses. Curr Allergy Asthma Rep. 2006; 6 (06) 502-507
  • 55 Branstetter IV BF, Weissman JL. Role of MR and CT in the paranasal sinuses. Otolaryngol Clin North Am. 2005; 38 (06) 1279-1299 , x
  • 56 Som PM, Lidov M, Brandwein M, Catalano P, Biller HF. Sinonasal esthesioneuroblastoma with intracranial extension: marginal tumor cysts as a diagnostic MR finding. AJNR Am J Neuroradiol. 1994; 15 (07) 1259-1262
  • 57 Sievers KW, Greess H, Baum U, Dobritz M, Lenz M. Paranasal sinuses and nasopharynx CT and MRI. Eur J Radiol. 2000; 33 (03) 185-202
  • 58 Koka VN, Julieron M, Bourhis J, Janot F, Le Ridant AM, Marandas P. , et al. Aesthesioneuroblastoma. J Laryngol Otol. 1998; 112 (07) 628-633
  • 59 Slevin NJ, Irwin CJ, Banerjee SS, Gupta NK, Farrington WT. Olfactory neural tumours--the role of external beam radiotherapy. J Laryngol Otol. 1996; 110 (11) 1012-1016
  • 60 Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993; 32 (05) 706-714 , discussion 714–715
  • 61 Biller HF, Lawson W, Sachdev VP, Som P. Esthesioneuroblastoma: surgical treatment without radiation. Laryngoscope. 1990; 100 (11) 1199-1201
  • 62 Konuthula N, Iloreta AM, Miles B, Rhome R, Ozbek U, Genden EM. , et al. Prognostic significance of Kadish staging in esthesioneuroblastoma: An analysis of the National Cancer Database. Head Neck. 2017; 39 (10) 1962-1968
  • 63 Gallia GL, Reh DD, Salmasi V, Blitz AM, Koch W, Ishii M. Endonasal endoscopic resection of esthesioneuroblastoma: the Johns Hopkins Hospital experience and review of the literature. Neurosurg Rev. 2011; 34 (04) 465-475
  • 64 Hanna E, DeMonte F, Ibrahim S, Roberts D, Levine N, Kupferman M. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol Head Neck Surg. 2009; 135 (12) 1219-1224
  • 65 Diaz Jr EM, Johnigan 3rd RH, Pero C, El-Naggar AK, Roberts DB, Barker JL. , et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck. 2005; 27 (02) 138-149
  • 66 Su SY, Kupferman ME, DeMonte F, Levine NB, Raza SM, Hanna EY. Endoscopic resection of sinonasal cancers. Curr Oncol Rep. 2014; 16 (02) 369
  • 67 Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Buencamino R. , et al. Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg. 2010; 113 (02) 340-351
  • 68 Schwartz JS, Palmer JN, Adappa ND. Contemporary management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surg. 2016; 24 (01) 63-69
  • 69 Folbe A, Herzallah I, Duvvuri U, Bublik M, Sargi Z, Snyderman CH. , et al. Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study. Am J Rhinol Allergy. 2009; 23 (01) 91-94
  • 70 Loy AH, Reibel JF, Read PW, Thomas CY, Newman SA, Jane JA. , et al. Esthesioneuroblastoma: continued follow-up of a single institution's experience. Arch Otolaryngol Head Neck Surg. 2006; 132 (02) 134-138
  • 71 Saade RE, Hanna EY, Bell D. Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep. 2015; 17 (01) 423
  • 72 Bhattacharyya N, Thornton AF, Joseph MP, Goodman ML, Amrein PC. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Results in 9 cases. Arch Otolaryngol Head Neck Surg. 1997; 123 (01) 34-40
  • 73 Loy AH, Reibel JF, Read PW, Thomas CY, Newman SA, Jane JA. , et al. Esthesioneuroblastoma: continued follow-up of a single institution's experience. Arch Otolaryngol Head Neck Surg. 2006; 132 (02) 134-138
  • 74 Saade RE, Hanna EY, Bell D. Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep 2015; (17) 1-5
  • 75 Bhattacharyya N, Thornton AF, Joseph MP, Goodman ML, Amrein PC. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation: results in 9 cases. Arch Otolaryngol Head Neck Surg. 1997; 123 (01) 34-40